[heckel NEWS LETTER] 2018년 11월호

관리자 2018.11.28 조회 336
1) Whole-body hyperthermia study on treatment of major depression at Charite Berlin
Department of Psychiatry and Psychotherapy at the Charité Campus Mitte has just started a randomized, double-blind controlled study of the efficacy of infrared-whole body hyperthermia in patients with major depression.
This study replicates basically the Arizona-Study with a higher number of patients (82 pts.). Additionally, patients with stable antidepressive medication are included. 

A verum and a sham arm are compared. More information at Deutsches Register Klinischer Studien
as well as at WHO International Clinical Trials Registry Platform.  Information about study participation at Charite-Homepage.

2) St. George Hospital publishes results of Lyme disease treatment using combined extreme whole-body hyperthermia / antibiotics

Dr. med. Friedrich R. Douwes 
Komplextherapie der chronischen Borreliose (Lyme Disease)
Ein neuer Therapieansatz: die Antibiotika augmentierte
Thermoeradikation (AAT)
OM & Ernährung 2018 / Nr. 164 [Article in German]

Borrelia is a genus of spirochaetes and are thermosensitive.
That opens up a new effective therapeutic option for chronic Lyme disease in the tradition of Wagner-Jaueregg who developed in the pre-antibiotic age, the so-called Malaria therapy to treat progressed Syphilis (also caused by spirochaetes) by deliberate infection with Malaria provoking the concomitant fever attacks. For this treatment approach he received the Nobel Prize in Medicine in 1927. In 1996 Reisinger et al. show an extraordinary increase of efficacy of antibiotics against Borrelia Burgdorferi under elevated temperatures.

For more than 15 years St. George Hospital has been developing the method of "Antibiotika Augmented Thermoeradication“ (AAT) - based on unexpected ameliorations in patients assumed to suffer from Lyme Disease additionally to the cancer disease that was originally being treated. Extreme whole-body hyperthermia using heckel-HT3000 up to approximately 41.6°C is directly combined with the antibiotic Ceftriaxon, β-Lactam, and Metronidazol.

Treatment results of 809 patients of the past 3 years showed a very good - good clinical outcome in approximately three-quarters of the patients, measured by a reduction of Burroscano-Score of at least 50%.
Even heckel company has recently been receiving several emails and phone calls from thankful patients from USA, whose often long lasting suffering has ended or has significangtly improved.
3) Installation of a new heckel-HT3000 in Coimbra / Portugal
Our Portuguese partner has successfully introduced heckel whole-body hyperthermia to Portugal.
After the installation of heckel-HT3000 systems in 3 oncological hospital departments and clinics in 2017 and 2018 a fourth system was installed in November in the Clinic for Integrative Medicine "Clinic4you": https://www.clinic4you.pt/

4) German Society of Hyperthermia (DGHT) issues (German) guidelines for whole-body hyperthermia
The Deutsche Gesellschaft für Hyperthermie e.V. (DGHT) has published guidelines for whole-body hyperthermia. They are available at this Link. 
Aside from the description of minimum standards of the procedure, the important indications of mild and fever-range WBH are listed and - at the first time - ranked according to their level of evidence.

5-2) Impressions from MEDICA DÜSSELDORF:

본 내용은 독일 heckel gmbH.에서 발행한 뉴스레터입니다.